Active Clinical Pipeline (unspecified)
Musculoskeletal repair, tissue rejuvenation, advanced healing
Key Facts
About Skye Biologics
Skye Biologics is a vertically integrated, private biotechnology company pioneering regenerative therapies based on its proprietary extracellular matrix (ECM) preservation technology. It currently commercializes a range of tissue allograft products for advanced wound care, surgical, and ocular applications through its sister tissue bank, while actively developing a clinical pipeline aimed at repairing musculoskeletal injuries and degenerative conditions. The company targets a massive market opportunity, aiming to address a $100+ billion healthcare spend by providing biologics that enhance healing, reduce complications, and lower long-term treatment costs. With a foundation in human placental tissue processing, Skye seeks to 'hack' the healing loop to restore tissue function across multiple high-need specialties.
View full company profile